Amophar OTC SRL
Amophar OTC reported total assets of 272,827 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jul 2026).
The score of Amophar OTC shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +35 % Total assets -43 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Amophar OTC's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 08 Oct 2024
Amophar OTC's financial analysis
- Solvency5.5%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Amophar OTC
Amophar OTC's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0795.483.142
- VAT number
- BE0795483142
- Peppol
- Registered · 0208:0795483142 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Dec 2022
- Registered office
- 2627 Schelle
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Amophar OTC (SRL) has been based in Schelle since 2022, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 3,725 € and equity of 15,024 €; its revenue is not published. Its solvency stands at 5.5%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Amophar OTC
Companies in the same business, of comparable size and area, outside its group.
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Cosmedic Wholesale of pharmaceutical and medical goods Boechout · balance sheet 331,807 €
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- NBS Scientific Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 152,659 €
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
Frequently asked questions about Amophar OTC
What is the revenue of Amophar OTC?
Amophar OTC files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Amophar OTC?
In Belgium, the VAT number is the company number prefixed with BE: BE0795483142 for Amophar OTC, if the company is VAT-registered. Its company number (CBE) is 0795.483.142.
Where is the registered office of Amophar OTC?
According to the CBE register, the registered office of Amophar OTC is in 2627 Schelle.
What is the equity of Amophar OTC?
At the close of the 2025 financial year, the equity of Amophar OTC amounts to 15,024 €, a solvency of 5.5% of total assets.
Who manages Amophar OTC?
The register lists 4 active mandates at Amophar OTC. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Amophar OTC
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →